GRSFF yields 32786.89% · PFE yields 6.13%● Live data
📍 GRSFF pulled ahead of the other in Year 1
Combined, GRSFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GRSFF + PFE for your $10,000?
Greencastle Resources Ltd. engages in the exploration and development of gold, base metal, oil and gas properties, and royalties. The company operates through Investments in Private and Public Companies; Oil and Gas Interests; and Mining Interests segments. It holds interests in two oil and gas properties, which include Primate and Primate North projects located in Saskatchewan, as well as the Ferrier project located in Alberta, Canada. The company also holds interests in the Jewel Ridge project and the Indian Creek project located in Nevada; and the Mayflower property consists of 64 claims located in the northwestern Ontario. In addition, it has an option agreement to earn 100% interest in the Seagrave property consists of 131 claim units located in the Birch-Uchi Greenstone Belt, Red Lake Mining Division in northwestern Ontario. Greencastle Resources Ltd. was founded in 1996 and is headquartered in Toronto, Canada.
Full GRSFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.